KSS vs CVS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
KSS · Kohl's Corp$22.25 ▼ 3.22%
CVS · CVS Health$80.84 ▲ 1.00%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- KSS +45.7%
- CVS +6.2%
Head to head
| Metric | KSS | CVS |
|---|---|---|
| Price | $22.25 | $80.84 |
| Change today | ▼ 3.22% | ▲ 1.00% |
| Market cap | $2.52B | $103.43B |
| Return, 3 months | +22.4% | -14.1% |
| Return, year to date | +11.7% | +4.2% |
| Return, 1 year | +45.9% | +6.0% |
| P/E (TTM) | 9.5 | 9.4 |
| P/B | 0.6 | 1.3 |
| P/E percentile vs own 5y | 93rd | 7th |
| Dividend yield | 2.25% | 3.29% |
| Revenue growth (YoY, latest qtr) | -0.9% | +5.4% |
| Net profit growth (YoY) | -1.3% | +154.4% |
| Gross margin | 41.2% | 14.2% |
| Operating margin | 3.9% | 3.6% |
| Net margin | 1.7% | 2.6% |
| Return on equity | 6.7% | 14.4% |
| Analyst target vs. price | -19.1% | +36.6% |
| Analyst buy share | 17% | 100% |
| RSI (14) | 46 | 37 |
| 30-day volatility | 64.9% | 51.7% |
| Max drawdown, 1 year | -51.8% | -27.3% |
| Trend read | Mixed | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CVS is the largest of the group by market value.
- KSS has returned the most over the past year.
- CVS carries the lowest trailing P/E.
- CVS pays the highest dividend yield.
- CVS is growing revenue fastest.
- CVS keeps the most profit per dollar of sales.
- CVS has been the calmest stock over the last 30 days.